Bernhard R. M. Ehmer
Chairman at BIOTEST AG
Net worth: 94 515 $ as of 2024-03-30
Network origin in Bernhard R. M. Ehmer first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Ludwig-Maximilians-Universität München
54
| College/University | Other Consumer Services | 54 |
45
| Public Company | Pharmaceuticals: Major | 45 |
28
| Public Company | Pharmaceuticals: Other | 28 |
24
| Public Company | Biotechnology | 24 |
Ruprecht-Karls-Universität Heidelberg
16
| College/University | Other Consumer Services | 16 |
| Public Company | Pharmaceuticals: Major | 14 | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The private company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Boehringer Mannheim GmbH
2
| Extinct | 2 | |
| Public Company | Biotechnology | 2 | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bernhard R. M. Ehmer via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| BASF SE | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| GRIFOLS, S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member General Counsel | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Grifols Diagnostic Solutions, Inc.
 Grifols Diagnostic Solutions, Inc. Pharmaceuticals: MajorHealth Technology Grifols Diagnostic Solutions, Inc. manufactures and markets plasma medicines and medical tools. Its services include blood group genotyping testing, IRL serology testing, prenatal testing, biological drug monitoring tests, FH genetic testing and other genetic testing. The company is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BMW AG | Motor Vehicles | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MWB FAIRTRADE WERTPAPIERHANDELSBANK AG | Investment Banks/Brokers | Chief Executive Officer Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Allianz Versicherungs AG
 Allianz Versicherungs AG Multi-Line InsuranceFinance Allianz Versicherungs-AG engages in the non-life insurance business. It provides general accident, liability, vehicle, legal expense, fire, credit and surety, as well as transport insurance services. The company is headquartered in Munich, Germany. | Multi-Line Insurance | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
| University of Kiel | College/University | Doctorate Degree Chairman | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University College London | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| University of Barcelona | College/University | Graduate Degree Graduate Degree | |
| University of Hannover | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Grifols USA, Inc.
 Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | Medical Specialties | Director/Board Member Director/Board Member General Counsel | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Public Communications Contact Chief Tech/Sci/R&D Officer | |
Bundesverband der Deutschen Industrie e.V.
 Bundesverband der Deutschen Industrie e.V. Miscellaneous Commercial ServicesCommercial Services Bundesverband der Deutschen Industrie e.V. provides information on the German industry, economy, and economic policies. The private company is based in Berlin, Germany. The German company organizes events that bring together business, politics, science, and civil society for discussions, whether virtually, in-person, or hybrid. The company was founded by Gerhard Schempp. | Miscellaneous Commercial Services | Corporate Officer/Principal President | |
BPC Plasma, Inc.
 BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Biomat USA, Inc.
 Biomat USA, Inc. Medical/Nursing ServicesHealth Services Biomat USA, Inc. provides plasma derived blood products. The company is headquartered in Los Angeles, CA. | Medical/Nursing Services | Director/Board Member Chairman | |
| SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | Biotechnology | Director/Board Member Director/Board Member | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Chairman | |
Tojosnura SL
 Tojosnura SL Miscellaneous Commercial ServicesCommercial Services Tojosnura SL provides legal services. The company was founded by Tomas Daga Gelabert and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Max-Planck-Institut für Chemie | College/University | Doctorate Degree Graduate Degree | |
VCN Biosciences SL
 VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The private company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Deutsche Akademie der Technikwissenschaften eV
 Deutsche Akademie der Technikwissenschaften eV Miscellaneous Commercial ServicesCommercial Services Deutsche Akademie der Technikwissenschaften eV advises on technical and technological issues for engineering and applied sciences. The private company is based in Munich, Germany. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member Director/Board Member | |
| Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal Director/Board Member | ||
Probitas Foundation
 Probitas Foundation Miscellaneous Commercial ServicesCommercial Services Probitas Foundation promotes and finances various activities and cooperative programs to improve healthcare. The private company is based in Barcelona, Spain. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman Director/Board Member Chief Executive Officer Founder Founder | |
Grifols Innovation & New Technologies Ltd.
 Grifols Innovation & New Technologies Ltd. BiotechnologyHealth Technology Grifols Innovation & New Technologies Ltd. provides research and experimental development services in biotechnology sector. The company was founded on December 21, 2015 and is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member Chief Executive Officer | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Biotest Pharma GmbH
 Biotest Pharma GmbH Pharmaceuticals: OtherHealth Technology Biotest Pharma GmbH engages in the manufacture and distribution of medicinal and pharmaceutical products. The company is headquartered in Dreieich, Germany. | Pharmaceuticals: Other | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal |
Statistics
International
| Germany | 22 |
| United States | 11 |
| Spain | 6 |
| Switzerland | 5 |
| United Kingdom | 5 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 11 |
| Commercial Services | 9 |
| Finance | 4 |
| Process Industries | 3 |
Operational
| Director/Board Member | 442 |
| Corporate Officer/Principal | 240 |
| Chairman | 119 |
| Chief Executive Officer | 112 |
| Independent Dir/Board Member | 71 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Erwin Kern | 38 |
| Edwin Moses | 35 |
| Karl-Ludwig Kley | 32 |
| Martin Madaus | 30 |
| Alexander Dibelius | 28 |
| Tomás Dagá Gelabert | 27 |
| Ferdinand Verdonck | 25 |
| Thomas O. Hecht | 24 |
| Berndt A. E. Modig | 23 |
| Jost Massenberg | 23 |
| Stefan Oschmann | 23 |
| Mathieu Simon | 22 |
| Harry Welten | 22 |
| Raimon Grifols Roura | 22 |
- Stock Market
- Insiders
- Bernhard R. M. Ehmer
- Company connections
